Axumin PET Scans: A Breakthrough for Prostate Cancer
BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …
P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Biopsy-proven local relapse in the residual prostate after radiation is usually managed with cryotherapy rather than with surgery. Cryotherapy and surgery both potentially cause incontinence. However, the risk of incontinence from cryotherapy is substantially lower than it is with surgery. New experimental approaches are under investigation using genetically altered viruses, laser, and in some cases, a second round of radiation using radioactive seeds.